Armata Pharmaceuticals (ARMP) EBITDA Margin (2013 - 2020)
Armata Pharmaceuticals (ARMP) posted EBITDA Margin of 14806.45% for Q2 2020, down 25.21% sequentially from 11825.0% in Q4 2017.
Armata Pharmaceuticals (ARMP) EBITDA Margin (2013 - 2020) Analysis & Trends
Armata Pharmaceuticals has reported EBITDA Margin for 6 years, with the latest figure at 14806.45% in Q2 2020.
- Quarterly EBITDA Margin changed N/A year-over-year to 14806.45% in Q2 2020, while the trailing twelve-month figure through Jun 2020 was 17661.54% (changed N/A YoY) and the FY2017 annual result came in at 14048.7%, down 505716.0% from the prior year.
- EBITDA Margin fell to 14806.45% in Q2 2020 per ARMP's latest filing, from 11825.0% in the prior quarter.
- Over five years, EBITDA Margin peaked at 1963.16% in Q3 2017 and troughed at 53927.27% in Q4 2016.
- A 3-year average of 16465.83% and a median of 11748.28% in 2016 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2016 and 2017: EBITDA Margin plunged 5163040 bps in 2016, then jumped 4210227 bps in 2017.
- Over 3 years, EBITDA Margin stood at 53927.27% in 2016, then soared by 78 bps to 11825.0% in 2017, then declined by 25 bps to 14806.45% in 2020.
- According to Business Quant data, EBITDA Margin over the past three periods registered 14806.45%, 11825.0%, and 1963.16% for Q2 2020, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -14,806.45% |
| Dec 31, 2017 | -11,825.00% |
| Sep 30, 2017 | -1,963.16% |
| Jun 30, 2017 | -34,592.86% |
| Mar 31, 2017 | -11,582.76% |
| Dec 31, 2016 | -53,927.27% |
| Sep 30, 2016 | -11,748.28% |
| Jun 30, 2016 | -3,484.47% |
| Mar 31, 2016 | -4,262.26% |
| Dec 31, 2015 | -2,296.88% |
| Sep 30, 2015 | -1,697.90% |
| Jun 30, 2015 | -2,541.18% |
| Mar 31, 2015 | -2,222.55% |
| Dec 31, 2014 | -2,571.29% |
| Sep 30, 2014 | -5,078.64% |
| Jun 30, 2014 | -3,710.89% |
| Mar 31, 2014 | -2,436.54% |
| Dec 31, 2013 | 1,026.19% |
| Sep 30, 2013 | -78,033.33% |
| Jun 30, 2013 | -1,950.32% |